GOLDMAN SACHS GROUP INC - VASCULAR BIOGENICS LTD ownership

VASCULAR BIOGENICS LTD's ticker is VBLT and the CUSIP is M96883109. A total of 15 filers reported holding VASCULAR BIOGENICS LTD in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
GOLDMAN SACHS GROUP INC ownership history of VASCULAR BIOGENICS LTD
ValueSharesWeighting
Q2 2021$40,000
+73.9%
16,556
+44.1%
0.00%
Q1 2021$23,000
-8.0%
11,487
-40.6%
0.00%
Q2 2020$25,000
-64.3%
19,347
+22.3%
0.00%
Q2 2017$70,0000.0%15,817
+34.1%
0.00%
Q4 2014$70,00011,7910.00%
Other shareholders
VASCULAR BIOGENICS LTD shareholders Q3 2020
NameSharesValueWeighting ↓
Lion Point Capital, LP 2,593,286$4,382,0001.02%
Telemetry Investments, L.L.C. 75,000$127,0000.20%
Ikarian Capital, LLC 830,747$1,404,0000.18%
DLD Asset Management, LP 550,000$930,0000.06%
Phoenix Holdings Ltd. 1,020,000$1,724,0000.03%
Spectrum Planning & Advisory Services Inc. 16,000$27,0000.02%
BOOTHBAY FUND MANAGEMENT, LLC 79,716$135,0000.00%
HBK Sorce Advisory LLC 22,325$38,0000.00%
B. Riley Wealth Management, Inc. 12,000$20,0000.00%
TWO SIGMA SECURITIES, LLC 12,155$21,0000.00%
View complete list of VASCULAR BIOGENICS LTD shareholders